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Abstract
Background: Centromere protein H (CENP-H) is one of the fundamental components of the
human active kinetochore. Recently, CENP-H was identified to be associated with tumorigenesis.
This study was aimed to investigate the clinicopathologic significance of CENP-H in tongue cancer.
Methods: RT-PCR, real time RT-PCR and Western blot were used to examine the expression of
CENP-H in tongue cancer cell lines and biopsies. CENP-H protein level in paraffin-embedded
tongue cancer tissues were tested by immunohistochemical staining and undergone statistical
analysis. CENP-H-knockdown stable cell line was established by infecting cells with a retroviral
vector pSuper-retro-CENP-H-siRNA. The biological function of CENP-H was tested by MTT assay,
colony formation assay, and Bromodeoxyuridine (BrdU) incorporation assay.
Results: CENP-H expression was higher in tongue cancer cell lines and cancer tissues (T) than that
in normal cell and adjacent noncancerous tongue tissues (N), respectively. It was overexpressed in
55.95% (94/168) of the paraffin-embedded tongue cancer tissues, and there was a strong
correlation between CENP-H expression and clinical stage, as well as T classification. CENP-H can
predict the prognosis of tongue cancer patients especially those in early stage. Depletion of CENP-
H can inhibit the proliferation of tongue cancer cells (Tca8113) and downregulate the expression
of Survivin.
Conclusion: These findings suggested that CENP-H involves in the development and progression
of tongue cancer. CENP-H might be a valuable prognostic indicator for tongue cancer patients
within early stage.
Background
The kinetochore is a large protein complex assembled on
centromere DNA and kinetochore dysfunction is an
important source for chromosome instability [1,2]. More
than 60 kinetochore proteins have been identified in yeast
in recent years [3-5]. Multiple kinetochore proteins have
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been shown to be deregulated in human cancers, which
suggests an important role of kinetochore for chromo-
some instability and cancer development [6-9].
CENP-H was initially identified in the mouse centromere
as a fundamental component of the active centromere
[10,11]. Human CENP-H presented at the inner plate of
kinetochore throughout the cell cycle, co-localized with
CENP-A and CENP-C, and was necessary for the appropri-
ate localization of CENP-C [10-13]. Recent report demon-
strated that the CENP-H-I complex was required for the
efficient incorporation of newly synthesized CENP-A into
centromere [14]. These findings indicate that CENP-H
might play an essential role in kinetochore assembly and
function throughout the cell cycle. CENP-H is also
strongly correlated with human cancer. It's expression was
deregulated in colorectal cancers, and ectopic overexpres-
sion of CENP-H induces chromosome instability in dip-
loid cell lines [6]. In addition, CENP-H was deregulated in
oral squamous cell carcinomas (SCCs), nasopharyngeal
carcinoma (NPC), and esophageal carcinoma [15-17].
The expression of CENP-H might be a valuable prognostic
marker which could predict the early stage NPC [15]. Fur-
ther more, the expression of CENP-H in oral SCCs was sig-
nificantly correlated with the cell proliferation in
malignant conditions[17].
Genomic aberrations including aneuploidy in epithelial
cells of the oral mucosa indicate high risks of oral cancer
and cancer-related mortality [18]. Tongue cancer is one of
the most common and serious types of oral cancer with
poor prognosis [19,20]. It is of great clinical value to iden-
tify efficient proliferation markers and valuable markers
that help to find tongue cancer patients at very early stage.
In this study, we investigated the expression of CENP-H in
tongue cancer and evaluated the role of CENP-H in prolif-
eration of tongue cancer cells.
Methods
Cell cultures
Primary cultured normal tongue mucosa epithelial cells
(TEC) were maintained in Keratinocyte-SFM (Gibco, Inv-
itrogen Corp, USA). Tongue cancer cell lines TSCCa and
Tca8113 were cultured in RPMI 1640 medium supple-
mented with 10% fetal calf serum (HyClone, Logan, UT).
Vectors and retroviral infection
Silence endogenous CENP-H, RNAi oligonucleotides (5-
GGATCCTGCCCTTAAGGAAAT-3) was cloned into the
pSuper-retro-puro vector to generate pSuper-retro-CENP-
H-siRNA. Retroviral production and infection were per-
formed as described previously[21]. Stable Tca8113 cells
expressing CENP-H RNAi were selected for 10 days with
CENP-H expression was tested in normal tongue cell line and tongue cancer cell lines Figure 1
CENP-H expression was tested in normal tongue cell line and tongue cancer cell lines. (A) Expression of CENP-H 
protein in normal tongue cell line TEC and cultured tongue cancer cell lines TSCCa and Tca8113. (B) and (C) CENP-H mRNA 
level analyzed by RT-PCR and Real-time RT-PCR.
Table 1: Primer Sequences Used for Reverse Transcription-PCR and Real-time Quantitative RT-PCR (5' to 3')
Gene Forward primer Reverse primer Probe
RT-PCR CENP-H TGCAAGAAAAGCAAATCGAA ATCCCAAGATTCCTGCTGTG
GAPDH CCACCCATGGCAAATTCCATG
GCA
TCTAGACGGCAGGTCAGGTCC
AC
Real-time PCR CENP-H CCTTATTTTGGGGAGTAAAGT
CAAT
ACAAATGCACAGAAGTATTCC
AAAT
FAM-TTCCTTAAGGGCAGGATCCT-
TAMRA
GAPDH GACTCATGACCACAGTCCATG
C
AGAGGCAGGGATGATGTTCTG FAM-
CATCACTGCCACCCAGAAGACTGTG-
TAMRA
Full gene names: CENP-H, centromere protein H;GAPDH, glyceraldehyde-3-phosphate dehydrogenaseJournal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
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0.5 lg/ml puromycin 48 h after infection. After 10 days
selection, the Tca8113 cell lysates prepared from the
pooled population of cells in sample buffer were fraction-
ated on sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis for the detection of CENP-H protein level.
Patients and tissue specimens
The present study was performed on 168 cases of paraffin-
embedded archived tongue cancer samples obtained from
the Department of Pathology, the Second Affiliated Hos-
pital of Sun Yat-sen University (PR China). Prior patients'
consents and approval from the Institutional Research
Ethics Committee were obtained for the purpose of
research. The final study population included 61 female
and 107 male patients (age range, 24–82 years). The
median follow-up time for overall survival was 63.14
months (range, 3–169 months) for patients who were still
alive at the time of the analysis. The resected tumors were
CENP-H expression in human tongue cancer tissues (T) and adjacent tongue tissues (N) Figure 2
CENP-H expression in human tongue cancer tissues (T) and adjacent tongue tissues (N). (A) Comparative 
expression levels of CENP-H mRNA in six noncancerous and tongue cancer samples by RT-PCR. GAPDH was used as an 
internal control. (B) Comparative expression levels of in six noncancerous and tongue cancer samples by Western blot. 
Expression levels were normalized for α-Tubulin. (C) Real time-PCR analysis of CENP-H expression in each of the T and N tis-
sues. GADPH was used as internal control. Columns, mean from three parallel experiments; bars, SD.Journal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
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classified according to the current International Union
Against Cancer (UICC) tumor-node-metastasis (TNM)
classification [22,23].
RT-PCR and real-time RT-PCR
RT-PCR and real-time RT-PCR analysis were performed as
described previously [24]. The primers and probes for RT-
PCR and the real-time RT-PCR were designed with Primer
Express v 2.0 (Applied Biosystems, Inc.) and provided in
Table 1.
Western blot
Western blot analysis was performed as described previ-
ously[15,24] using anti-CENP-H (Bethyl Laboratories,
Montgomery, Texas, USA), anti-α-Tubulin (Sigma, Saint
Louis, Michigan, USA), anti-p21, anti-p27 and anti-Rb
antibodies (Cell Signaling, Danvers, Massachusetts, USA).
Immunohistochemical analysis
The staining procedures and result measure of CENP-H
were done as described previously[15,24]. The cells at
each intensity of staining were recorded on a scale of 0 (no
staining), 1 (weak staining = light yellow), 2 (moderate
staining = yellowish brown), and 3 (strong staining =
brown). An intensity score of ≥ 2 with at least 50% of
malignant cells with positive CENP-H staining was used
to classify tumors with high expression, and < 50% of
malignant cells with nuclear staining or < 2 intensity score
classified tumors with low expression of CENP-H.
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) assay
Growing cells (5 × 103 per well) were seeded into 96-well
plates. Cells were stained with 100 μl sterile MTT dye (0.5
mg/ml, Sigma, St. Louis, Missouri, USA) at each time
point, followed by additional incubation for 4 h at 37°C.
After removal of the culture medium from each well, 150
μl of dimethyl sulphoxide (Sigma, St. Louis, MO, USA)
was added and thoroughly mixed for 15 min. The optical
density was read at 570 nm using a microplate reader
(Bio-Rad 3500, Hercules, California, USA), with 655 nm
as the reference wavelength. All experiments were per-
formed in triplicate.
Colony formation assays
Cells were seeded in 6-well plates (1×103 cells per well)
and cultured for two weeks. The colonies were fixed with
methanol for 10 min and stained with 1% crystal violet
for 1 min. Each group of cells was performed in triplicate.
Bromodeoxyuridine (BrdU) incorporation and 
immunofluorescence
Cells grown on cover slips (Fisher, Pittsburgh, Pennsylva-
nia, USA) were synchronized by serum starvation
(0.5%FBS) for 48 h and then released into serum-contain-
ing medium for 4 h. The cells were labelled by incubating
in 10-μM bromodeoxyuridine (BrdU) for 1 hour, fixed
with 4% paraformaldehyde and stained with anti-BrdUrd
antibody (Upstate, Temecula, California, USA). The cover
slips were imaged with a con-focal laser-scanning micro-
scope (Axiovert 200 M, Zeiss). At least 500 nuclei were
count to determine the proportion of positive nuclei
(BrdU index). All values presented are the means of at
least three independent experiments.
Statistical analysis
All statistical analyses were performed using the SPSS 13.0
statistical software package. The Mann-Whitney U test and
Spearman's correlation coefficient by log-rank test were
used to assess the relationship between CENP-H expres-
sion and clinicopathologic parameters. Overall survival
curves were plotted by the Kaplan-Meier method and were
compared by the log-rank test. The Cox proportional haz-
ards regression model was used for multivariate analysis.
Table 2: Correlation between CENP-H expression and the clinicopathological characteristics of the tongue cancer patients
Characteristics CENP-H Mann-Whitney U P-value
Low or None (%) High (%)
Clinical stage
I 30(40.5) 8(8.5) 0.005
II 10(13.5) 31(33.0)
III 21(28.4) 39(41.5)
IV 13(17.6) 16(17.0)
T classification
T1 21(28.4) 7(7.4) 0.004
T2 39(52.7) 60(63.8)
T3 8(10.8) 12(12.8)
T4 6(8.1) 15(16.0)
N classification
N0 47(63.5) 49(52.1) 0.172
N1 26(35.1) 44(46.8)
N2 1(1.4) 1(1.1)Journal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
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Student's t-test was used to compare the values between
subgroups in all cases analyzed by real-time RT-PCR. In all
cases, a P value of less than 0.05 in all cases was consid-
ered statistically significant. All P values were two-tailed.
Results
CENP-H expression is elevated in human tongue cancer 
cells and primary tongue cancers
Western blot analyses on normal tongue mucosa epithe-
lial cells (TEC) and two tongue cancer cell lines (TSCCa
and Tca8113) revealed that CENP-H protein was highly
expressed in cancer cells, while it was only weakly
detected in TEC cells (Figure 1A). The RT-PCR results dis-
played a higher expression of CENP-H mRNA in cancer
cell lines than that in normal tongue cells (Figure 1B).
Real-time RT-PCR results showed higher level of CENP-H
mRNA in comparison with TEC cells, increasing up to 15-
fold in both tongue cancer cell lines (Figure 1C). In addi-
tion, both CENP-H protein and mRNA were overex-
pressed in all six cases of tongue cancer biopsies compared
with that in the matched adjacent noncancerous tissues
(Figure 2A and 2B). The quantitative PCR showed that the
CENP-H protein expression in paraffin-embedded tongue cancer tissue samples and its prognostic value Figure 3
CENP-H protein expression in paraffin-embedded tongue cancer tissue samples and its prognostic value. (A) 
Representative images of CENP-H protein expression examined by immunohistochemistry (IHC). CENP-H was only negatively 
or marginally detectable in non-cancerous tongue tissue (a, 200× and b, 400×), while it was positive in tongue cancer cells (c, 
200× and d, 400×). (B) Upper panel: Overall survival of tongue cancer patients with low CENP-H expression versus high 
CENP-H-expressing tumors plotted with Kaplan-Meier analysis. Lower panel: Statistical significance of the difference between 
curves of CENP-H high-expression and low-expression patients was compared in stage I and stage II patient subgroups. P val-
ues were calculated by log-rank test.
Table 3: Univariate and multivariate analyses of prognostic parameters in tongue cancer patients by Cox-regression analysis
Univariate analysis Multivariate analysis
No. patients P Regression coefficient
(SE)
P Relative risk 95% confidence interval
Clinical stage < 0.001 0.829(0.121) < 0.001 2.291 1.807–2.903
I–II 95
III – IV 96
CENP-H 0.001 0.444(0.219) 0.043 1.559 1.014–2.903
Low expression 96
High expression 95Journal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
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tumor/normal (T/N) ratio of CENP-H mRNA levels were
diversity from approximately 4 to 20-fold (Figure 2C).
immunohistochemical analysis further confirmed this
result (Figure 2D). These observations suggested that high
CENP-H expression was associated with the clinical pro-
gression of tongue cancer.
Clinicopathological significance of CENP-H in human 
tongue cancer tissues
55.95% (94/168) of the samples were highly detected by
the rabbit-human CENP-H polyclonal antibody (Figure
3A). Signals were mainly observed in the cancerous areas,
and no or only weak signals were detected in the normal
tissues (Figure 3A). Additional file 1 shows that the
immunohistochemical staining signal with CENP-H anti-
body could be completely blocked by recombinant
CENP-H polypeptide. This result indicated that the CENP-
H antibody used in the present study specifically recog-
nizes the CENP-H protein.
Mann-Whitney U test showed that CENP-H expression
was strongly correlated with clinical stage (P = 0.005) and
T classification (P = 0.004). While no significant associa-
tion was found between CENP-H level and lymph node
metastasis (P = 0.172) (Table 2). There were also no sig-
nificant correlations between the CENP-H expression
level and age or gender (data not shown). Kaplan-Meier
survival analysis showed a better outcome for patients
who with low CENP-H level (Figure 3B, upper panel). The
median survival period for patients with high CENP-H
expression levels was substantially shorter (53 months)
than that for patients with low CENP-H expression levels
(76 months) (P = 0.0006, log-rank test). Multivariate Cox
regression analysis revealed that the relationship between
CENP-H expression and overall survival remained
unchanged even when adjustments were made for tumor
stage (Table 3). Additionally, CENP-H expression and
overall survival were significantly correlated in stage I (n =
38, P = 0.0033) and stage II (n = 41, P = 0.0117) sub-
groups of patients (Figure 3B, lower panel). However, no
such correlation was observed with regard to a subgroup
of patients with stage III (data not shown). These results
suggest that CENP-H can predict the prognosis of tongue
cancer in patients only in the early stage of the disease.
Downregulation of CENP-H inhibits proliferation of 
Tca8113 cells
The impact of CENP-H expression on tongue cancer pro-
liferation was evaluated in CENP-H knockdown cells (Fig-
ure 4). As shown in Figure 4A, the depletion of CENP-H
expression caused significantly compromised viability in
Tca81133 cells. The population doubling time cells of
CENP-H RNAi are significantly shorter as compared with
control (Figure 4A, P < 0.05). BrdU incorporation assays
also demonstrated a significant inhibition of proliferation
in Tca8113/CENP-H RNAi cells as compared to the con-
Knock down of CENP-H inhibits the proliferation of Tca8113 cells Figure 4
Knock down of CENP-H inhibits the proliferation of Tca8113 cells. (A) Effect of CENP-H knockdown in proliferation 
of Tca8113 was determined by MTT assays. (B) BrdU incorporation assay (upper panel) and colony formation assay (lower 
upper). Upper: The cells were fixed and subjected to BrdU staining and visualization under a fluorescence microscope. Data 
were obtained from three independent experiments with similar results. Green:Brdu; Blue:DAPI. Lower: The photographs of 
crystal violet stained Tca8113/control siRNA and Tca8113/CENP-H siRNA. Data were obtained form three independent 
experiments with similar results. (C) Cell lysates were prepared for western blot analysis of antibodies against CENP-H and 
Survivin. α-Tubulin was detected as an internal control.Journal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
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trol cells (Figure 4B, upper panel, P < 0.01). Colony for-
mation assay revealed that Tca8113/CENP-H RNAi cells
formed much less and smaller colonies than that of con-
trol Tca8113 cells (Figure 4B, lower panel, P  = 0.01).
These results suggested that CENP-H is essential for the
proliferation of Tca8113 cells in vitro.
CENP-H regulates Survivin expression in tongue cancer 
cells
As deregulation of the CENP-H expression firmly linked
with proliferation of tongue cancer cells, we further inves-
tigated the modulate cell cycle factors which could be reg-
ulated by CENP-H. Western blot analysis revealed that the
expression level of Survivin in CENP-H knockdown cells
was significantly downregulated as compared with con-
trol cells (Figure 4C).
Discussion
Defects in kinetochore function are responsible for chro-
mosome instability and the generation of cancer. Several
kinetochore proteins have been shown to be deregulated
in human oral SCCs. CENP-F and Survivin expression
were elevated in oral SCCs [25]. CENP-H was upregulated
in human oral SCCs and CENP-H mRNA expression level
was significantly correlated with the clinical stage of this
disease. Higher CENP-H mRNA level predicted poor prog-
nosis of oral SCC patients [17]. In the present study, we
found that CENP-H was upregulated in oral tongue cancer
cells and tongue cancer tissue samples both at transcrip-
tional levels and at translational levels, indicating that
CENP-H might play a crucial role in the human tongue
cancer. We also found that CENP-H level was positively
correlated with the clinical stage and T classification.
These results indicate the possible role of CENP-H in pro-
gression of oral tongue cancer. Furthermore, we found
that CENP-H expression was a significant predictor of
poor prognosis for a subgroup of patients with early-stage
cancer according to the clinical stage. Together with our
results, CENP-H may be a new biomarker of early-stage
tongue cancer.
Recently, several studies have documented that deregula-
tion of kinetochore proteins frequently occur in cancer
development and progression [6,14-17,26-28]. Shigeishi
et al. reported that CENP-H was derugulated in oral SCCs
and closely linked to the increased or abnormal cell pro-
liferation in malignant conditions [17]. Since our results
showed that CENP-H was deregulated in tongue cancer,
we consider whether change of CENP-H expression level
can affect the growth of tongue cancer cells. In fact, we
found that downregulation of CENP-H significantly
inhibits the proliferation of tongue cancer cells.
We further investigated the potential mechanism by
which CENP-H inhibits the proliferation rate of tongue
cancer cells (Tca8113). We found that the expression level
of Survivin in CENP-H-kncokdown Tca8113 cells was sig-
nificantly downregulated as compared with control cells.
As an essential chromosome passenger protein, Survivin
exhibits a dynamic interaction with centromeres, concen-
trated at the inner centromere at metaphase [29]. Survivin
also belongs to the inhibitor of apoptosis protein family
and functions as an essential regulator of cell division and
apoptosis, and it ensuring continued cell proliferation
and cell survival in unfavorable milieus [30-32]. Survivin
is overexpressed in most oral SCCs and its high expression
can predict poor prognosis of oral SCCs patients [33].
Additionally, expression of Survivin is an early event dur-
ing oral carcinogenesis [34]. In the present study, we
found that depletion of CENP-H can downregulate the
expression of Survivin protein. Thus, the clinical and bio-
logical significance of CENP-H and Survivin oral cancer
including tongue cancer suggested that both deregulation
of Survivin and CENP-H were early event in development
of this kind of cancer.
In summary, the present study not only demonstrated the
possible role of CENP-H in the development and progres-
sion of tongue cancer, but also suggested the possibility of
using CENP-H as a prognostic indicator for tongue cancer
patients within early stage. To our knowledge, this is the
first report showing that ectopic expression of CENP-H
could significantly enhance proliferation of tongue cancer
cells though upregulation of Survivin expression. How-
ever, the molecular mechanisms by which CENP-H upreg-
ulate Survivin expression need to be investigated in future.
Conclusion
In conclusion, expression of CENP-H was associated with
clinical stage and T classification of tongue cancer, as well
as poor prognosis of tongue cancer patients. Down-regu-
lation of CENP-H can inhibit the proliferation of tongue
cancer cells. These findings suggested that CENP-H play
an important role in development and progression of
tongue cancer. It also might be a valuable prognostic
biomarker for early stage tongue cancer patients.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
WL carried out cell cultures, establishment of stable cell
lines, proliferation functional assays, and preparation of
manuscript. CY and DW participated in RT-PCR and
immunohistochemistry, as well as data analysis. LX and
GW have been involved in western blot analysis and data
interpretation. LZ participated in critical revision of the
manuscript. MZ participated in the study design and coor-
dination and helped to revise the manuscript. LS and JL
conceived of the study, participated in experimentalJournal of Experimental & Clinical Cancer Research 2009, 28:74 http://www.jeccr.com/content/28/1/74
Page 8 of 8
(page number not for citation purposes)
design and coordination, and involved in data analysis
and helped to draft the manuscript. All authors read and
approved the final manuscript.
Additional material
Acknowledgements
Grant support: Science and Technology Bureau Foundation of Guang Zhou 
(2008Z1-E201). National Natural Science Foundation of China grants, 
30470666, and 30570701, 30670803, 30770836. The Ministry of Science 
and Technology of China grant 2004CB518708, the National Natural Sci-
ence Foundation of Guangdong Province, China, grants 04009427 and 
5001749, and a key grant from 985-II project. Municipal Science and Tech-
nology Bureau Foundation of Guang Zhou (2060302).
References
1. Fukagawa T: Assembly of kinetochores in vertebrate cells.  Exp
Cell Res 2004, 296:21-27.
2. Cleveland DW, Mao Y, Sullivan KF: Centromeres and kineto-
chores: from epigenetics to mitotic checkpoint signaling.  Cell
2003, 112:407-421.
3. Westermann S, Cheeseman IM, Anderson S, Yates JR 3rd, Drubin
DG, Barnes G: Architecture of the budding yeast kinetochore
reveals a conserved molecular core.  J Cell Biol 2003,
163:215-222.
4. Cheeseman IM, Drubin DG, Barnes G: Simple centromere, com-
plex kinetochore: linking spindle microtubules and centro-
meric DNA in budding yeast.  J Cell Biol 2002, 157:199-203.
5. De Wulf P, McAinsh AD, Sorger PK: Hierarchical assembly of the
budding yeast kinetochore from multiple subcomplexes.
Genes Dev 2003, 17:2902-2921.
6. Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai
T, Yoda K, Nomura F: Centromere protein H is up-regulated in
primary human colorectal cancer and its overexpression
induces aneuploidy.  Cancer Res 2005, 65:4683-4689.
7. Barbanis S, Ioannou M, Kouvaras E, Karasavvidou F, Nakou M, Papam-
ichali R, Koukoulis G: INCENP (Inner Centromere Protein) is
Overexpressed in High Grade Non-Hodgkin B-cell Lympho-
mas.  Pathol Oncol Res 2009, 15:11-17.
8. Erlanson M, Casiano CA, Tan EM, Lindh J, Roos G, Landberg G:
Immunohistochemical analysis of the proliferation associ-
ated nuclear antigen CENP-F in non-Hodgkin's lymphoma.
Mod Pathol 1999, 12:69-74.
9. Shigeishi H, Mizuta K, Higashikawa K, Yoneda S, Ono S, Kamata N:
Correlation of CENP-F gene expression with tumor-prolifer-
ating activity in human salivary gland tumors.  Oral Oncol 2005,
41:716-722.
10. Sugata N, Munekata E, Todokoro K: Characterization of a novel
kinetochore protein, CENP-H.  J Biol Chem 1999,
274:27343-27346.
11. Fukagawa T, Mikami Y, Nishihashi A, Regnier V, Haraguchi T, Hiraoka
Y, Sugata N, Todokoro K, Brown W, Ikemura T: CENP-H, a con-
stitutive centromere component, is required for centro-
mere targeting of CENP-C in vertebrate cells.  Embo J 2001,
20:4603-4617.
12. Sugata N, Li S, Earnshaw WC, Yen TJ, Yoda K, Masumoto H,
Munekata E, Warburton PE, Todokoro K: Human CENP-H mul-
timers colocalize with CENP-A and CENP-C at active cen-
tromere – kinetochore complexes.  Hum Mol Genet 2000,
9:2919-2926.
13. Cheeseman IM, Hori T, Fukagawa T, Desai A: KNL1 and the
CENP-H/I/K Complex Coordinately Direct Kinetochore
Assembly in Vertebrates.  Mol Biol Cell 2008, 19:587-594.
14. Hori T, Okada M, Maenaka K, Fukagawa T: CENP-O class proteins
form a stable complex and are required for proper kineto-
chore function.  Mol Biol Cell 2008, 19:843-854.
15. Liao WT, Song LB, Zhang HZ, Zhang X, Zhang L, Liu WL, Feng Y, Guo
BH, Mai HQ, Cao SM, Li MZ, Qin HD, Zeng YX, Zeng MS: Centro-
mere protein H is a novel prognostic marker for nasopharyn-
geal carcinoma progression and overall patient survival.  Clin
Cancer Res 2007, 13:508-514.
16. Guo XZ, Zhang G, Wang JY, Liu WL, Wang F, Dong JQ, Xu LH, Cao
JY, Song LB, Zeng MS: Prognostic relevance of Centromere
protein H expression in esophageal carcinoma.  BMC Cancer
2008, 8:233.
17. Shigeishi H, Higashikawa K, Ono S, Mizuta K, Ninomiya Y, Yoneda S,
Taki M, Kamata N: Increased expression of CENP-H gene in
human oral squamous cell carcinomas harboring high-prolif-
erative activity.  Oncol Rep 2006, 16:1071-1075.
18. Reshmi SC, Gollin SM: Chromosomal instability in oral cancer
cells.  J Dent Res 2005, 84:107-117.
19. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK,
Myers JN: Extent of extracapsular spread: a critical prognos-
ticator in oral tongue cancer.  Cancer 2003, 97:1464-1470.
20. Haddadin KJ, Soutar DS, Webster MH, Robertson AG, Oliver RJ,
MacDonald DG: Natural history and patterns of recurrence of
tongue tumours.  Br J Plast Surg 2000, 53:279-285.
21. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu
QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX:
Bmi-1 is a novel molecular marker of nasopharyngeal carci-
noma progression and immortalizes primary human
nasopharyngeal epithelial cells.  Cancer Res 2006, 66:6225-6232.
22. Patel SG, Shah JP: TNM staging of cancers of the head and neck:
striving for uniformity among diversity.  CA Cancer J Clin 2005,
55:242-258.
23. O'Sullivan B, Shah J: New TNM staging criteria for head and
neck tumors.  Semin Surg Oncol 2003, 21:30-42.
24. Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS,
Song LB: Centromere protein H is a novel prognostic marker
for human nonsmall cell lung cancer progression and overall
patient survival.  Cancer 2009, 115:1507-1017.
25. Jane C, Nerurkar AV, Shirsat NV, Deshpande RB, Amrapurkar AD,
Karjodkar FR: Increased survivin expression in high-grade oral
squamous cell carcinoma: a study in Indian tobacco chewers.
J Oral Pathol Med 2006, 35:595-601.
26. Kops GJ, Weaver BA, Cleveland DW: On the road to cancer: ane-
uploidy and the mitotic checkpoint.  Nat Rev Cancer 2005,
5:773-785.
27. de la Guardia C, Casiano CA, Trinidad-Pinedo J, Baez A: CENP-F
gene amplification and overexpression in head and neck
squamous cell carcinomas.  Head Neck 2001, 23:104-112.
28. Clark GM, Allred DC, Hilsenbeck SG, Chamness GC, Osborne CK,
Jones D, Lee WH: Mitosin (a new proliferation marker) corre-
lates with clinical outcome in node-negative breast cancer.
Cancer Res 1997, 57:5505-5508.
29. Carvalho A, Carmena M, Sambade C, Earnshaw WC, Wheatley SP:
Survivin is required for stable checkpoint activation in taxol-
treated HeLa cells.  J Cell Sci 2003, 116:2987-2998.
30. Lens SM, Vader G, Medema RH: The case for Survivin as mitotic
regulator.  Curr Opin Cell Biol 2006, 18:616-622.
31. Altieri DC: Survivin, versatile modulation of cell division and
apoptosis in cancer.  Oncogene 2003, 22:8581-8589.
32. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri
DC: Control of apoptosis and mitotic spindle checkpoint by
survivin.  Nature 1998, 396:580-584.
33. Lo Muzio L, Farina A, Rubini C, Pezzetti F, Stabellini G, Laino G,
Santarelli A, Pannone G, Bufo P, de Lillo A, Carinci F: Survivin as
prognostic factor in squamous cell carcinoma of the oral cav-
ity.  Cancer Lett 2005, 225:27-33.
34. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De
Rosa G, Kudo Y, Takata T, Altieri DC: Survivin, a potential early
predictor of tumor progression in the oral mucosa.  J Dent Res
2003, 82:923-928.
Additional file 1
Validation for the specificity of CENP-H antibody. Tongue cancer sec-
tions were incubated with CENP-H antibody alone or previously co-incu-
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